Log In
Print this Print this

Teleukin (F16-IL2)

  Manage Alerts
Collapse Summary General Information
Company Philogen S.p.A.
DescriptionHuman vascular targeting immunocytokine consisting of the human vascular targeting antibody F16 and of human interleukin-2
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today